TechAccel co-funds the development, de-risking and advancement of technologies that fill partner portfolio gaps — pairing equity with science advancement for university researchers and Global Industry Strategics alike.
TechAccel exists to advance innovation that Global Industry Strategics can't fund alone — de-risking early technology through co-funded development so it's ready for commercialization, not just publication.
We co-fund development and de-risking, taking an equity position alongside technical, regulatory and commercialization support — not just a check.
Discuss a technologyDirect partnerships with universities and research institutes to move discovery-stage science toward de-risked, fundable technology.
Founded in 2014 as a first-of-its-kind organization, TechAccel's vision is to increase food production and quality to enhance human health through technology innovation — a mission stated verbatim on techaccel.net.
A structured path for university researchers and industry partners bringing forward Ag, Animal Health, or Food Tech innovation.
TechAccel evaluates the science against portfolio gaps identified with Global Industry Strategics.
Equity and science-advancement resources are committed to move the technology forward.
Technical, regulatory and commercial risk is reduced in structured stages before wider industry adoption.
Proven technology moves into subsidiaries, joint ventures, or licensing with strategic partners.
TechAccel's Kansas City-area headquarters and St. Louis office keep the team close to major agricultural research and animal-health corridors.
RNAissance Ag is named directly on techaccel.net; the remaining tiles are illustrative investment categories, not specific company names, pending a full portfolio list from the client.
TechAccel deliberately stays inside three categories, so partner relationships with Global Industry Strategics can leverage deep, specific technical expertise instead of generalist coverage.